Welcome to the Stocktwits Top 25 Newsletter this week!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date and tracks their performances over time. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!

Here are the Stocktwits Top 25 Lists for this week:

D-Wave is hosting its first-ever Investor Day (in-person and virtual) on June 1, 2026, to help investors understand:

Why it matters: If you’re following $QBTS, this is a must-attend event to understand D-Wave’s leadership position, commercial momentum, and path to long-term growth.

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

The Russell momentum board is still stuffed with AI hardware, space proxies, and turnaround stories with very little room for boring.

$RDW ( ▼ 5.14% ) : Redwire, #20 and this week’s top dawg: Redwire ripped +41% WTD and is now up +223% YTD, with Stocktwits sentiment at 95% bullish and 20.3k watchers. The move fits the SpaceX IPO proxy bid, but Friday’s Blue Origin blast showed how fast space enthusiasm can become launch-risk repricing. Risk: this is still a speculative space-infrastructure trade, and proxy heat can leave faster than contracts arrive.

$RXT ( ▲ 6.6% ) : Rackspace, held #3: Rackspace climbed +25% WTD and is up +433% YTD as traders keep treating the AMD AI infrastructure MOU as a real turnaround spark. The sentiment score is only 38%, which makes the move more interesting: price is running well ahead of community conviction. Risk: leverage and execution still matter, and AI partnership headlines need to turn into revenue.

$HYLN ( ▼ 2.78% ) : Hyliion, held #11: Hyliion jumped +17% WTD and is up +280% YTD as the KARNO power-module pivot keeps pulling in energy, defense, and data-center speculators. Its 71% sentiment score and 38.7k watchers make it one of the more visible turnaround names on the list. Risk: the whole story depends on commercialization timing, not just cool-generator enthusiasm.

$ERAS ( ▲ 5.25% ) : Erasca, held #15: Erasca rose +14% WTD and is up +245% YTD, giving biotech traders one of the cleaner momentum charts on the screen. Sentiment is still only 40%, which says the tape has improved faster than the crowd’s trust. Risk: this remains a clinical-stage biotech, so trial updates can erase technical setups in one session.

$VSH ( ▼ 0.36% ) : Vishay, held #14: Vishay climbed +10% WTD and is up +259% YTD, putting old-school components into the same momentum conversation as sexier semiconductor names. Sentiment is neutral at 52%, but the move says investors are still paying for the broader electronics recovery. Risk: if industrial orders soften, components lose the AI-adjacent glow quickly.

Off the list this week: The table only shows four new entrants: $KOS, $VICR, $SPIR, and $HURA. That makes this less of a wholesale reshuffle and more of a momentum board where the leaders mostly held their spots.

Next week’s swing factor: Monday’s ISM Manufacturing print and Friday’s May jobs report test the whole basket. A clean growth read keeps AI hardware and industrial tech bid, while a wobble makes the crowded YTD winners look very tall.

Help us deliver the best content possible by completing this brief survey. 📝

Want to see some change? Email Kevin Travers your feedback; follow him on Stocktwits.

Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital, and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The Content is to be used for informational and entertainment purposes only and the Service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on Content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which Content is published on the Service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍

Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋